Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuzhou Xianzhilou is a prominent Chinese biotechnology enterprise dedicated to the organic cultivation, research, and processing of medicinal fungi, particularly Ganoderma lucidum (Reishi). The company maintains a vertically integrated supply chain, from its GAP-certified organic plantations in the Wuyi Mountains to its GMP-certified manufacturing facilities. Their product line includes high-purity spore oil, cell-wall broken spore powder, and various fungal extracts used in health supplements and traditional medicine. Xianzhilou is a key contributor to national and international standards for Ganoderma products and exports its GanoHerb brand globally. The company focuses on leveraging advanced extraction and cell-wall breaking technologies to maximize the bioavailability of fungal polysaccharides and triterpenoids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuzhou Xianzhilou.